Table 3.
Ratio of MFI between α2δ1 versus control in ascites samples of gastric cancer patients
| Sample | Percentage of α2δ1 | MFI | Ratio | |
|---|---|---|---|---|
| α2δ1 | Control | |||
| Case 1 | 30.5 | 6,7128.53 | 14,267.03 | 4.72 |
| Case 2 | 0.1 | 21,379.60 | 16,869.24 | 1.27 |
| Case 3 | 0.5 | 5,531.14 | 5,012.46 | 1.10 |
| Case 4 | 11.2 | 94,299.57 | 37,966.42 | 2.48 |
| Case 5 | 26.1 | 33,638.29 | 9,631.68 | 3.49 |
| Case 6 | 0.3 | 1,826.10 | 2,693.33 | 1.48 |
| Case 7 | 28.9 | 79,353.95 | 19,983.89 | 3.97 |
| Case 8 | 0.4 | 1,936.05 | 1,463.52 | 1.32 |
| Case 9 | 0.3 | 2,455.17 | 2,103.87 | 1.17 |
| Case 10 | 0.1 | 610.14 | 523.52 | 1.16 |
Notes: Ratio is calculated as MFI of α2δ1/MFI of control.
Abbreviation: MFI, mean fluorescence intensity.